Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma OncLive
Finance, IT & News
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma OncLive
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel…
Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and ... Yahoo Finance
What Does the FDA Approval of Orally Disintegrating Nilotinib Tablets Mean for CML Practice? OncLive
FDA Approves Orzeyful (Oveporexton) for Adults With Narcolepsy Type 1 WebMD